FBIO Long Call Strategy
FBIO (Fortress Biotech, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases). Other products in this segment are Exelderm cream for fungal skin infections like ringworm and jock itch, Ceracade for dry skin conditions, Luxamend for wound care, and Accutane capsules for particularly severe, stubborn nodular acne. Its pipeline features several promising late-stage drug candidates, targeting a diverse range of medical needs. These include intravenous Tramadol for acute post-operative pain, CUTX-101 (an injection for Menkes disease), MB-107 and MB-207 for X-linked severe combined immunodeficiency, Cosibelimab for metastatic cancers, CK-101 for non-small cell lung cancer characterized by EGFR mutations, CAEL-101 for amyloid light chain (AL) amyloidosis, the Triplex vaccine for cytomegalovirus, and CEVA101 for critical traumatic brain injuries in adults and children.
FBIO (Fortress Biotech, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $91.4M, a trailing P/E of 0.68, a beta of 1.21 versus the broader market, a 52-week range of 1.91-4.53, average daily share volume of 510K, a public-listing history dating back to 2011, approximately 78 full-time employees. These structural characteristics shape how FBIO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.21 places FBIO roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 0.68 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a long call on FBIO?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
FBIO snapshot
As of August 14, 2026, spot at $2.89, ATM IV 74.00%, IV rank 11.37%, expected move 21.22%. The long call on FBIO below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on FBIO specifically: FBIO IV at 74.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a FBIO long call, with a market-implied 1-standard-deviation move of approximately 21.22% (roughly $0.61 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FBIO expiries trade a higher absolute premium for lower per-day decay. Position sizing on FBIO should anchor to the underlying notional of $2.89 per share and to the trader's directional view on FBIO stock.
FBIO long call setup
The FBIO long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FBIO at $2.89 on that close, the first option leg uses a $2.89 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FBIO chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FBIO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.89 | N/A |
FBIO long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
FBIO long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on FBIO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on FBIO
Long calls on FBIO express a bullish thesis with defined risk; traders use them ahead of FBIO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
FBIO thesis for this long call
The market-implied 1-standard-deviation range for FBIO extends from approximately $2.28 on the downside to $3.50 on the upside. A FBIO long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current FBIO IV rank near 11.37% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on FBIO at 74.00%. As a Healthcare name, FBIO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FBIO-specific events.
FBIO long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FBIO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FBIO alongside the broader basket even when FBIO-specific fundamentals are unchanged. Long-premium structures like a long call on FBIO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current FBIO chain quotes before placing a trade.
Frequently asked questions
- What is a long call on FBIO?
- A long call on FBIO is the long call strategy applied to FBIO (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With FBIO stock at $2.89 on the most recent close, the strikes shown on this page are snapped to the nearest listed FBIO chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are FBIO long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the FBIO long call priced from the end-of-day chain at a 30-day expiry (ATM IV 74.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FBIO long call?
- The breakeven for the FBIO long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The FBIO market-implied 1-standard-deviation expected move in the same options snapshot is approximately 21.22%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on FBIO?
- Long calls on FBIO express a bullish thesis with defined risk; traders use them ahead of FBIO catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current FBIO implied volatility affect this long call?
- FBIO ATM IV is at 74.00% with IV rank near 11.37%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.